Confirmatory phase III trial of dasiglucagon in severe hypoglycemia meets primary endpoint May 14, 2019
Sevuparin fails to show meaningful benefit in phase II trial to manage VOC in sickle cell disease May 14, 2019
DSMB 36-month review of phase III RESOLVE-IT trial of elafibranor in NASH recommends continuation May 14, 2019
RSS